Europe's pharmaceutical industry presents a intricate landscape rife with both possibilities. Regulators across the continent are increasingly enforcing stringent guidelines while patients seek affordable treatments. This fluctuating environment necessitates a proactive approach for pharmaceutical companies looking to succeed. Stakeholders must car